Dyadic International Inc (DYAI)
1.614
-0.04
(-2.19%)
USD |
NASDAQ |
May 20, 16:00
1.60
-0.01
(-0.86%)
Pre-Market: 20:00
Dyadic International Price to Book Value: 10.45 for May 20, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 20, 2024 | 10.45 |
| May 17, 2024 | 10.68 |
| May 16, 2024 | 10.75 |
| May 15, 2024 | 10.16 |
| May 14, 2024 | 9.647 |
| May 13, 2024 | 9.906 |
| May 10, 2024 | 9.387 |
| May 09, 2024 | 9.637 |
| May 08, 2024 | 9.258 |
| May 07, 2024 | 9.129 |
| May 06, 2024 | 9.452 |
| May 03, 2024 | 9.258 |
| May 02, 2024 | 9.712 |
| May 01, 2024 | 9.517 |
| April 30, 2024 | 9.258 |
| April 29, 2024 | 9.00 |
| April 26, 2024 | 9.647 |
| April 25, 2024 | 9.647 |
| April 24, 2024 | 9.712 |
| April 23, 2024 | 9.647 |
| April 22, 2024 | 9.906 |
| April 19, 2024 | 10.29 |
| April 18, 2024 | 10.29 |
| April 17, 2024 | 10.88 |
| April 16, 2024 | 11.63 |
| Date | Value |
|---|---|
| April 15, 2024 | 10.79 |
| April 12, 2024 | 11.38 |
| April 11, 2024 | 11.86 |
| April 10, 2024 | 11.70 |
| April 09, 2024 | 12.34 |
| April 08, 2024 | 12.09 |
| April 05, 2024 | 11.70 |
| April 04, 2024 | 12.02 |
| April 03, 2024 | 11.63 |
| April 02, 2024 | 11.31 |
| April 01, 2024 | 10.79 |
| March 31, 2024 | |
| March 28, 2024 | 8.231 |
| March 27, 2024 | 8.034 |
| March 26, 2024 | 7.744 |
| March 25, 2024 | 8.038 |
| March 22, 2024 | 7.842 |
| March 21, 2024 | 7.989 |
| March 20, 2024 | 8.185 |
| March 19, 2024 | 7.793 |
| March 18, 2024 | 7.744 |
| March 15, 2024 | 7.352 |
| March 14, 2024 | 7.450 |
| March 13, 2024 | 7.842 |
| March 12, 2024 | 7.254 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.968
Minimum
Mar 18 2020
12.34
Maximum
Apr 09 2024
5.391
Average
5.229
Median
Mar 02 2021
Price to Book Value Benchmarks
| AIM ImmunoTech Inc | 5.143 |
| Perspective Therapeutics Inc | 4.415 |
| Protalix BioTherapeutics Inc | 2.954 |
| Electromed Inc | 3.436 |
| Armata Pharmaceuticals Inc | -- |
Price to Book Value Related Metrics
| PS Ratio | 20.62 |
| Price | 1.614 |
| Earnings Yield | -17.35% |
| Market Cap | 47.19M |